CLASS III Drug recall · Reported 10 Apr 2013 · FDA Enforcement Report

Fougera Ketoconazole Cream 2% tube recalled by Fougera Pharmaceuticals

Fougera Pharmaceuticals is recalling Fougera Ketoconazole Cream 2% tube, distributed nationwide in the US. The recall was initiated on 18 Jul 2012 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #: 835H, Exp 07/12
NDC0168-0099
UPC0301680099156
Quantity recalled60,210 units

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-241-2013
FDA event ID
62625
Recalling firm
Fougera Pharmaceuticals, Melville, NY
Manufacturer
E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC
Classification
Class III
Status
Terminated
Recall initiated
18 Jul 2012
FDA classified
2 Apr 2013
Reported
10 Apr 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

18 Jul 2012Recall initiated by company
2 Apr 2013Classified by FDA+258 days
10 Apr 2013Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/Degradation Specifications: Ketoconazole Cream 2% is the subject of a voluntary drug recall by Fougera due to an Out Of Specification result for an unknown degradant product

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Fougera Ketoconazole Cream 2%, 15g tube, Rx only, Labeled with E. Fougera & Co., a division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0099-15

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Failed Impurities/Degradation Specifications: Ketoconazole Cream 2% is the subject of a voluntary drug recall by Fougera due to an Out Of Specification result for an unknown degradant product

Which lots are affected?

Lot #: 835H, Exp 07/12

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Fougera Pharmaceuticals

All 8

Other Ketoconazole recalls

All 4